Pharmacies Want Class Cert. In Pfizer Pay-For-Delay Case
A group of pharmacies urged a Tennessee federal judge on Wednesday to reconsider his refusal to certify classes of drug retailers targeting a pay-for-delay deal that suppressed competition to a muscle relaxant...To view the full article, register now.
Already a subscriber? Click here to view full article